Foundation Health, a startup founded in 2023 by a co-founder of the digital pharmacy company Truepill, has spent 2026 expanding deployment of PAIGE, an AI system built to automate the repetitive, time-consuming administrative work that specialty pharmacies handle for patients on complex medications. The company closed a 20 million dollar Series A funding round, led by Define Ventures with participation from Vanderbilt University and Intermountain Ventures, bringing its total funding to 26 million dollars, and has used that capital to expand PAIGE’s rollout at health systems including Intermountain Health.
What PAIGE Actually Automates
PAIGE is designed to handle refill processing, adherence outreach, calling or messaging patients to check whether they are taking medications as prescribed, benefits verification, and prior-authorization paperwork, the bureaucratic step that determines whether an insurer will pay for a prescribed drug before a pharmacy can dispense it. Foundation Health says these automated workflows reduce the manual workload on pharmacy staff by up to 75%, freeing pharmacists and technicians to spend more time on clinical counseling and complex cases rather than phone calls and paperwork.
The Intermountain Health Deployment
In July 2026, Foundation Health’s PAIGE platform was used to automate patient outreach and communication workflows in a six-month program at Intermountain Health’s specialty pharmacy operations, based in Midvale, Utah, which serves more than 14,000 patients on complex therapies. Specialty pharmacy, which handles high-cost drugs for conditions like cancer, autoimmune disease, and rare genetic disorders, is one of the most administratively burdensome corners of the pharmacy business, since these medications typically require extensive insurance authorization and ongoing adherence support that a standard retail pharmacy workflow was never built to handle at scale.
Why Prior Authorization Is the Real Bottleneck
Prior authorization has become one of the most criticized friction points in American healthcare, blamed by physicians and patients alike for delaying treatment and, in some cases, causing patients to abandon needed medications altogether rather than navigate the paperwork. Automating the administrative side of prior authorization, without changing who ultimately makes the coverage decision, is the pitch behind PAIGE and a wave of similar AI tools from competitors like Courier Health, which raised 50 million dollars in a Series B round in 2026 to build AI infrastructure for the broader biopharma patient experience, and BrightInsight, which raised 13 million dollars from investors including Mayo Clinic to expand its own AI-enabled medication adherence platform.
Where the Money and Institutional Backing Are Coming From
The involvement of Vanderbilt University and Intermountain Ventures as investors, alongside Intermountain Health as an actual deployment partner, signals a pattern increasingly common in health-tech funding: academic medical centers and health systems investing directly in the AI startups whose products they also plan to use, giving the startups both capital and a built-in reference customer. Foundation Health’s leadership has framed this alignment as a faster path to clinical validation than a typical vendor sales cycle, since a health system that has invested in a company has a direct incentive to make its deployment succeed.
What Pharmacists and Patient Advocates Are Watching
Pharmacy groups have generally welcomed automation of purely administrative tasks like refill reminders and paperwork routing, but have been more cautious about adherence outreach specifically, since a poorly designed AI messaging system could annoy or alienate patients managing serious illnesses rather than support them. Foundation Health has said PAIGE is scoped to automate outreach and communication, not clinical decision-making, and that pharmacists remain the ones interpreting adherence data and deciding whether to intervene with a patient directly, a division of labor similar to the human-in-the-loop framing used by AI tools in other parts of healthcare this year.
What Comes Next
Foundation Health’s near-term plan is to expand the Intermountain Health program beyond its initial six-month pilot and pursue similar deployments at other specialty pharmacy operations, using the Intermountain results as a reference case for future health-system sales. The broader test for PAIGE and its competitors will be whether automating the administrative side of specialty pharmacy actually reduces medication abandonment and improves adherence, outcomes that will take longer to measure than the efficiency gains vendors can report right away, but that ultimately determine whether health systems keep paying for these tools once initial pilot funding runs out. Investors backing Foundation Health and its rivals are, in effect, betting that the current wave of health-system pilots converts into multi-year contracts once hospitals see adherence and abandonment numbers move in the right direction, rather than remaining one-off proofs of concept that quietly wind down after the pilot period ends.
Photo: public domain via flickr
